# Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

> **NCT00006012** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 73 (actual)

## Conditions studied

- Drug/Agent Toxicity by Tissue/Organ
- Lung Cancer
- Radiation Toxicity

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** amifostine trihydrate
- **DRUG:** cisplatin
- **DRUG:** etoposide
- **DRUG:** paclitaxel
- **DRUG:** topotecan hydrochloride
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00006012
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006012, "Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00006012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*